HK Stock Market Move | AK MEDICAL (01789) rose more than 4% plans to repurchase up to HK$150 million worth of shares. It has won multiple joint bids in the 26-year history of Siasun Robot & Automation, pending public announcement.

AK MEDICAL (01789) rose more than 4%, as of press time, up 2.97%, to 5.89 Hong Kong dollars, with a turnover of 92.586 million Hong Kong dollars. On the news front, on February 2, AK MEDICAL announced that the directors planned to use shares to repurchase the authorized shares and, depending on the market conditions, to publicly use up to 150 million Hong Kong dollars on the Hong Kong Stock Exchange for the proposed share repurchase, until the expiration date of the share repurchase authorization. The company plans to provide funds for the proposed share repurchase from its internal financial resources. The company plans to cancel all repurchased shares after settlement in accordance with applicable rules and regulations. It is worth mentioning that, according to AK MEDICAL's official microblog, on January 15, 2026, the joint replacement surgery navigation positioning system (National Medical Device Registration No. 20263010104) declared by AK MEDICAL's subsidiary Yidian Lingdong has obtained the NMPA's approval for a Class III medical device registration certificate, covering hip, knee, and unicompartmental indications, and can also be used for revision surgery. As of now, the company has deployed nearly a hundred joint Siasun Robot & Automation products in the market, forming an effective synergy with the original prosthetic business, and several joint Siasun Robot & Automation products have been awarded bids to be publicly displayed in 2026, forming a closed-loop from medical engineering to clinical application.